{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T12:06:48Z","timestamp":1792843608723,"version":"4.5.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T00:00:00Z","timestamp":1684281600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T00:00:00Z","timestamp":1684281600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocr Pathol"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1007\/s12022-023-09770-4","type":"journal-article","created":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T11:01:56Z","timestamp":1684321316000},"page":"234-246","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["High Grade Differentiated Follicular Cell-Derived Thyroid Carcinoma Versus Poorly Differentiated Thyroid Carcinoma: A Clinicopathologic Analysis of 41 Cases"],"prefix":"10.1007","volume":"34","author":[{"given":"Lester D. R.","family":"Thompson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,17]]},"reference":[{"issue":"17","key":"9770_CR1","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1200\/JCO.21.00714","volume":"40","author":"AL Ho","year":"2022","unstructured":"Ho AL, Dedecjus M, Wirth LJ, Tuttle RM, Inabnet WB, 3rd, Tennvall J, et al. Selumetinib Plus Adjuvant Radioactive Iodine in Patients With High-Risk Differentiated Thyroid Cancer: A Phase III, Randomized, Placebo-Controlled Trial (ASTRA). J Clin Oncol. 2022;40(17):1870-8.","journal-title":"J Clin Oncol."},{"issue":"1","key":"9770_CR2","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s12022-022-09707-3","volume":"33","author":"ZW Baloch","year":"2022","unstructured":"Baloch ZW, Asa SL, Barletta JA, Ghossein RA, Juhlin CC, Jung CK, et al. Overview of the 2022 WHO Classification of Thyroid Neoplasms. Endocr Pathol. 2022;33(1):27-63.","journal-title":"Endocr Pathol."},{"issue":"6","key":"9770_CR3","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1089\/thy.2020.0668","volume":"31","author":"KS Wong","year":"2021","unstructured":"Wong KS, Dong F, Telatar M, Lorch JH, Alexander EK, Marqusee E, et al. Papillary Thyroid Carcinoma with High-Grade Features Versus Poorly Differentiated Thyroid Carcinoma: An Analysis of Clinicopathologic and Molecular Features and Outcome. Thyroid. 2021;31(6):933-40.","journal-title":"Thyroid."},{"issue":"3","key":"9770_CR4","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s12022-020-09627-0","volume":"31","author":"KS Wong","year":"2020","unstructured":"Wong KS, Lorch JH, Alexander EK, Marqusee E, Cho NL, Nehs MA, et al. Histopathologic Features and Clinical Outcome of Anaplastic Thyroid Carcinoma with a Minor Anaplastic Component. Endocr Pathol. 2020;31(3):283-90.","journal-title":"Endocr Pathol."},{"issue":"9","key":"9770_CR5","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1089\/thy.2019.0263","volume":"29","author":"KS Wong","year":"2019","unstructured":"Wong KS, Lorch JH, Alexander EK, Marqusee E, Cho NL, Nehs MA, et al. Prognostic Significance of Extent of Invasion in Poorly Differentiated Thyroid Carcinoma. Thyroid. 2019;29(9):1255-61.","journal-title":"Thyroid."},{"issue":"9","key":"9770_CR6","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1007\/s00268-019-05028-5","volume":"43","author":"J Akaishi","year":"2019","unstructured":"Akaishi J, Kondo T, Sugino K, Ogimi Y, Masaki C, Hames KY, et al. Prognostic Impact of the Turin Criteria in Poorly Differentiated Thyroid Carcinoma. World J Surg. 2019;43(9):2235-44.","journal-title":"World J Surg."},{"issue":"3","key":"9770_CR7","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1172\/JCI85271","volume":"126","author":"I Landa","year":"2016","unstructured":"Landa I, Ibrahimpasic T, Boucai L, Sinha R, Knauf JA, Shah RH, et al. Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers. J Clin Invest. 2016;126(3):1052-66.","journal-title":"J Clin Invest."},{"issue":"1","key":"9770_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1507\/endocrj.EJ14-0293","volume":"62","author":"K Kakudo","year":"2015","unstructured":"Kakudo K, Wakasa T, Ohta Y, Yane K, Ito Y, Yamashita H. Prognostic classification of thyroid follicular cell tumors using Ki-67 labeling index: risk stratification of thyroid follicular cell carcinomas. Endocr J. 2015;62(1):1-12.","journal-title":"Endocr J."},{"issue":"2","key":"9770_CR9","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1007\/s12022-015-9367-6","volume":"26","author":"S Bai","year":"2015","unstructured":"Bai S, Baloch ZW, Samulski TD, Montone KT, LiVolsi VA. Poorly differentiated oncocytic (h\u00fcrthle cell) follicular carcinoma: an institutional experience. Endocr Pathol. 2015;26(2):164-9.","journal-title":"Endocr Pathol."},{"issue":"2","key":"9770_CR10","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1111\/his.12246","volume":"64","author":"V Gnemmi","year":"2014","unstructured":"Gnemmi V, Renaud F, Do Cao C, Salleron J, Lion G, Wemeau JL, et al. Poorly differentiated thyroid carcinomas: application of the Turin proposal provides prognostic results similar to those from the assessment of high-grade features. Histopathology. 2014;64(2):263-73.","journal-title":"Histopathology."},{"issue":"8","key":"9770_CR11","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1177\/1066896914531814","volume":"22","author":"M Bongiovanni","year":"2014","unstructured":"Bongiovanni M, Mazzucchelli L, Giovanella L, Frattini M, Pusztaszeri M. Well-differentiated follicular patterned tumors of the thyroid with high-grade features can metastasize in the absence of capsular or vascular invasion: report of a case. Int J Surg Pathol. 2014;22(8):749-56.","journal-title":"Int J Surg Pathol."},{"issue":"7","key":"9770_CR12","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1111\/j.1365-2559.2012.04188.x","volume":"60","author":"M Dettmer","year":"2012","unstructured":"Dettmer M, Schmitt A, Steinert H, Moch H, Komminoth P, Perren A. Poorly differentiated oncocytic thyroid carcinoma--diagnostic implications and outcome. Histopathology. 2012;60(7):1045-51.","journal-title":"Histopathology."},{"issue":"8","key":"9770_CR13","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1097\/PAS.0b013e3180309e6a","volume":"31","author":"M Volante","year":"2007","unstructured":"Volante M, Collini P, Nikiforov YE, Sakamoto A, Kakudo K, Katoh R, et al. Poorly differentiated thyroid carcinoma: the Turin proposal for the use of uniform diagnostic criteria and an algorithmic diagnostic approach. Am J Surg Pathol. 2007;31(8):1256-64.","journal-title":"Am J Surg Pathol."},{"issue":"6","key":"9770_CR14","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1002\/cncr.21739","volume":"106","author":"D Hiltzik","year":"2006","unstructured":"Hiltzik D, Carlson DL, Tuttle RM, Chuai S, Ishill N, Shaha A, et al. Poorly differentiated thyroid carcinomas defined on the basis of mitosis and necrosis: a clinicopathologic study of 58 patients. Cancer. 2006;106(6):1286-95.","journal-title":"Cancer."},{"issue":"8","key":"9770_CR15","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1002\/jso.20697","volume":"94","author":"A Shaha","year":"2006","unstructured":"Shaha A. Treatment of thyroid cancer based on risk groups. J Surg Oncol. 2006;94(8):683-91.","journal-title":"J Surg Oncol."},{"issue":"5","key":"9770_CR16","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1002\/cncr.20087","volume":"100","author":"M Volante","year":"2004","unstructured":"Volante M, Landolfi S, Chiusa L, Palestini N, Motta M, Codegone A, et al. Poorly differentiated carcinomas of the thyroid with trabecular, insular, and solid patterns: a clinicopathologic study of 183 patients. Cancer. 2004;100(5):950-7.","journal-title":"Cancer."},{"issue":"2","key":"9770_CR17","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1177\/106689690201000205","volume":"10","author":"M Sobrinho-Sim\u00f5es","year":"2002","unstructured":"Sobrinho-Sim\u00f5es M, Sambade C, Fonseca E, Soares P. Poorly differentiated carcinomas of the thyroid gland: a review of the clinicopathologic features of a series of 28 cases of a heterogeneous, clinically aggressive group of thyroid tumors. Int J Surg Pathol. 2002;10(2):123-31.","journal-title":"Int J Surg Pathol."},{"issue":"6","key":"9770_CR18","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1097\/00000478-199906000-00007","volume":"23","author":"G Tallini","year":"1999","unstructured":"Tallini G, Garcia-Rostan G, Herrero A, Zelterman D, Viale G, Bosari S, et al. Downregulation of p27KIP1 and Ki67\/Mib1 labeling index support the classification of thyroid carcinoma into prognostically relevant categories. Am J Surg Pathol. 1999;23(6):678-85.","journal-title":"Am J Surg Pathol."},{"issue":"3","key":"9770_CR19","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1002\/ssu.2980110310","volume":"11","author":"TR Loree","year":"1995","unstructured":"Loree TR. Therapeutic implications of prognostic factors in differentiated carcinoma of the thyroid gland. Semin Surg Oncol. 1995;11(3):246-55.","journal-title":"Semin Surg Oncol."},{"key":"9770_CR20","unstructured":"Shaha AR, Loree TR, Shah JP. Intermediate-risk group for differentiated carcinoma of thyroid. Surgery. 1994;116(6):1036\u201340; discussion 40\u20131."},{"key":"9770_CR21","doi-asserted-by":"crossref","unstructured":"Carcangiu ML, Zampi G, Rosai J. Poorly differentiated (\"insular\") thyroid carcinoma. A reinterpretation of Langhans' \"wuchernde Struma\". Am J Surg Pathol. 1984;8(9):655\u201368.","DOI":"10.1097\/00000478-198409000-00005"},{"issue":"11","key":"9770_CR22","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1089\/thy.2016.0247","volume":"26","author":"B Xu","year":"2016","unstructured":"Xu B, Ibrahimpasic T, Wang L, Sabra MM, Migliacci JC, Tuttle RM, et al. Clinicopathologic Features of Fatal Non-Anaplastic Follicular Cell-Derived Thyroid Carcinomas. Thyroid. 2016;26(11):1588-97.","journal-title":"Thyroid."},{"issue":"2","key":"9770_CR23","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1111\/his.14550","volume":"80","author":"B Xu","year":"2022","unstructured":"Xu B, David J, Dogan S, Landa I, Katabi N, Saliba M, et al. Primary high-grade non-anaplastic thyroid carcinoma: a retrospective study of 364 cases. Histopathology. 2022;80(2):322-37.","journal-title":"Histopathology."},{"key":"9770_CR24","doi-asserted-by":"crossref","unstructured":"Xu B, Lubin DJ, Dogan S, Ghossein RA, Viswanathan K. Significance of oncocytic features in poorly differentiated thyroid carcinoma - a bi-institutional experience. Virchows Arch. 2023;482(3):479\u201391.","DOI":"10.1007\/s00428-022-03422-4"},{"key":"9770_CR25","unstructured":"Amin MG, DM; Meyer Vega, LR; Edge, SB; Greene, FL; Byrd, DR; Brookland, RK; Washington, MK; Compton, CC. American Joint Committee on Cancer Staging Manual. 8th ed. Amin M, editor. New York: Springer; 2018."},{"issue":"2","key":"9770_CR26","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.humpath.2009.08.011","volume":"41","author":"M Rivera","year":"2010","unstructured":"Rivera M, Ricarte-Filho J, Patel S, Tuttle M, Shaha A, Shah JP, et al. Encapsulated thyroid tumors of follicular cell origin with high grade features (high mitotic rate\/tumor necrosis): a clinicopathologic and molecular study. Hum Pathol. 2010;41(2):172-80.","journal-title":"Hum Pathol."},{"issue":"1","key":"9770_CR27","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/PAP.0000000000000380","volume":"30","author":"B Xu","year":"2023","unstructured":"Xu B, Ghossein RA. Advances in Thyroid Pathology: High Grade Follicular Cell-derived Thyroid Carcinoma and Anaplastic Thyroid Carcinoma. Adv Anat Pathol. 2023;30(1):3-10.","journal-title":"Adv Anat Pathol."},{"key":"9770_CR28","doi-asserted-by":"crossref","unstructured":"Juhlin CC, Mete O, Baloch ZW. The 2022 WHO classification of thyroid tumors: novel concepts in nomenclature and grading. Endocr Relat Cancer. 2023;30(2):e220293.","DOI":"10.1530\/ERC-22-0293"},{"issue":"5","key":"9770_CR29","doi-asserted-by":"publisher","first-page":"683","DOI":"10.5858\/133.5.683","volume":"133","author":"R Ghossein","year":"2009","unstructured":"Ghossein R. Problems and controversies in the histopathology of thyroid carcinomas of follicular cell origin. Arch Pathol Lab Med. 2009;133(5):683-91.","journal-title":"Arch Pathol Lab Med."},{"issue":"1","key":"9770_CR30","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s12022-021-09665-2","volume":"32","author":"M Volante","year":"2021","unstructured":"Volante M, Lam AK, Papotti M, Tallini G. Molecular Pathology of Poorly Differentiated and Anaplastic Thyroid Cancer: What Do Pathologists Need to Know? Endocr Pathol. 2021;32(1):63-76.","journal-title":"Endocr Pathol."}],"container-title":["Endocrine Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12022-023-09770-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12022-023-09770-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12022-023-09770-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T04:23:23Z","timestamp":1686630203000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12022-023-09770-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,17]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["9770"],"URL":"https:\/\/doi.org\/10.1007\/s12022-023-09770-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2631444\/v1","asserted-by":"object"}]},"ISSN":["1046-3976","1559-0097"],"issn-type":[{"value":"1046-3976","type":"print"},{"value":"1559-0097","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,17]]},"assertion":[{"value":"28 April 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in this study involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study was approved by the Institutional Review Board of Southern California Permanente Medical Group, IRB#5968.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Consent to participate was waived by the IRB due to the retrospective nature of the work without therapeutic alterations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Consent for publication was obtained from all individual participants for whom identifying information is uniquely included in this manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The author declares no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}